Manufacturer record

Mahendra Labs Pvt. Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

3 batches manufactured by Mahendra Labs Pvt. Ltd (Karnataka) were declared Not of Standard Quality between June 2025 and November 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

3 records linked to Mahendra Labs Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
3Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Jun 2025 to Nov 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

3
NSQ batches since 2025
3
Products affected
Dissolution
Most common failure
Nov 2025
Latest alert

Flagged batches per year

2025 · 3

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Glimepiride Tablets IP.2mg GP08Mfg 2024-09 · Exp 2027-08 Test for DissolutionDissolution RDTL, Hubli, KarnatakaState lab Nov 2025
Ciprox-TZ Suspension - Vet (Ciprofloxacin and Tinidazole Oral Suspension) CTL184Mfg 2024-10 · Exp 2026-09 Assay for TinidazoleAssay State Lab KarnatakaState lab Jun 2025
Albendazole Tablets IP 400 mg ZL70Mfg 2023-10 · Exp 2026-09 DissolutionDissolution State Lab KarnatakaState lab Jun 2025

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.